Research Studies

Browse Studies

SAGE-301 PURVIEW

Ongoing
Conditions:
HD

Criteria

Ages
25-65
Cognition
any
Dyskinesias
any
Fluctuations
No
Tremor
any
Gait
any
DBS
No
Hallucinations
any

About this study

This Phase 3 clinical trial is open to both participants who have previously been participating in the Dimension or Surveyor studies, as well as those who have not. The study is currently enrolling patients for its open label phase to receive the investigational drug, SAGE-718

Sustain our mission to enhance lives and outcomes through research

As we work to improve patient quality of life — for their entire lifespan — we seek partners to catapult our progress. With your philanthropic investment, we can expand the breadth and depth of our efforts in three critical areas: research, clinical care and education and training.

Support Us